All Posts By

Smartkarma Daily Briefs

Daily Brief Thematic (Sector/Industry): SGX FTSE Taiwan Index Futures – The Most Liquid Taiwan Offshore Contract and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • SGX FTSE Taiwan Index Futures – The Most Liquid Taiwan Offshore Contract
  • Will the Approval of Genuine Biotech’s COVID-19 Oral Drug Change China’s Zero-COVID Policy?

SGX FTSE Taiwan Index Futures – The Most Liquid Taiwan Offshore Contract

By Brian Freitas

  • The SGX FTSE Taiwan Index Futures are CFTC certified and started trading on 20 July 2020 and use the FTSE Taiwan RIC Capped Index as the underlying.
  • Volumes on the SGX FTSE Taiwan Index Futures have increased significantly since launch and the ADTV for July was US$3.34bn versus US$509m for the MSCI Taiwan Index Futures.
  • At US$4.86bn, open interest for the SGX FTSE Taiwan Index Futures is also substantially higher than the open interest on the MSCI Taiwan futures at US$797m.

Will the Approval of Genuine Biotech’s COVID-19 Oral Drug Change China’s Zero-COVID Policy?

By Xinyao (Criss) Wang

  • China approved the first self-developed COVID-19 oral drug (Azivudine), but there are controversies about efficacy and safety profile on it, which could increase the unpredictability of domestic innovative drugs approval.
  • Due to the VBP, fierce competition, uncertainties in the COVID-19 prevention/control policies and decreasing demand, the commercialization performance and outlook of Azivudine could be lower-then-expected in China and overseas markets.
  • The approval of Azivudine wouldn’t change the zero-COVID policy. Until President Xi’s third term appointment is confirmed, there’s no reason to expect China to deviate from this policy.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: Softbank Confirms BABA Selldown – Big Changes on Softie’s Balance Sheet and BABA Index Implications and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Softbank Confirms BABA Selldown – Big Changes on Softie’s Balance Sheet and BABA Index Implications
  • FTSE TWSE Taiwan Dividend+ Index Rebalance Preview: BIG Capping Changes in September
  • Shinoken (8909) MBO – Decent Premium, Still Light, Will Someone Push?
  • Looking at Canon Buyback Dynamics History – Patterns Vs Peers Gives Execution Hints
  • Kakao Games: Announces A Rights Offering Worth 197 Billion Won
  • Hong Kong CEO & Director Dealings – 10th August 2022
  • STI Index Rebalance Preview (Sep): Close to the Cutoffs
  • True/​​​DTAC: Merger Support Increasingly Tenuous
  • Siemens Energy/Siemens Gamesa: Downwards Guidance

Softbank Confirms BABA Selldown – Big Changes on Softie’s Balance Sheet and BABA Index Implications

By Travis Lundy

  • Softbank today confirmed that the stories circulating about Softbank having hedged a decent portion – 200+mm shares – of its BABA position were true. 
  • The market expectation had been that these pre-paid forwards would be held for another two years. The announcement today is that they will be physically settled early. 
  • This means the entire accounting effect – worth ¥4.6trln – will hit the income statement (and balance sheet) in the current quarter. There are investment and index implications

FTSE TWSE Taiwan Dividend+ Index Rebalance Preview: BIG Capping Changes in September

By Brian Freitas

  • We do not expect any deletions from the FTSE TWSE Taiwan Dividend+ Index in September, but there will be a lot of passive flow due to capping changes.
  • Based on the closing prices from 9 August, we estimate one-way turnover of 11.2% at the September rebalance resulting in a one-way trade of TWD 15,754m (US$525m).
  • Most stocks with expected passive inflows are trading near their recent lows (leading to higher dividend yield), while most stocks with expected passive outflows have rallied recently (lower dividend yields).

Shinoken (8909) MBO – Decent Premium, Still Light, Will Someone Push?

By Travis Lundy

  • Today Shinoken Group (8909 JP) announced it was the subject of an MBO where the CEO-founder invited Integral – a local PE fund – to help him restructure and grow.
  • It is at a 45% premium to last, and management negotiated the price from a relatively insulting initial bid of ¥1,300 to ¥1,600 in the end, but it’s still light.
  • It is not hugely light, but it is not a full price. It could definitely be a bit higher. The question is whether active foreigners will push. 

Looking at Canon Buyback Dynamics History – Patterns Vs Peers Gives Execution Hints

By Travis Lundy

  • Canon Inc (7751 JP) has just started its 17th buyback in 15 years. Like the 16 before, this one is for ¥50bn. 
  • The patterns/dynamics of the canon buybacks in the past are remarkable when compared to buybacks of other companies. 
  • There are outperformance and under-performance patterns vs Peers, and it is worth taking note if you have a position to trade. 

Kakao Games: Announces A Rights Offering Worth 197 Billion Won

By Douglas Kim

  • Kakao Games Corp (293490 KS) announced today a rights offering worth 197 billion won, representing 4.4% of its market cap.
  • Lionheart Studio’s founder and CEO Kim Jae-Young is expected to purchase 3.1 million shares of the rights offering (177 billion won), representing 90% of the total rights offering shares.
  • The issue with Kakao Games and Lionheart Studio remains the fact that many investors would rather invest in Lionheart when it completes its IPO, rather than indirectly through Kakao Games.

Hong Kong CEO & Director Dealings – 10th August 2022

By David Blennerhassett

  • The data in this insight is collated from the “shareholding disclosure” link on the HKEx website. 
  • Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. However, such disclosures are by no means an absolute. 
  • These insights also flag those companies where shares have been pledged, both recently and ongoing.

STI Index Rebalance Preview (Sep): Close to the Cutoffs

By Brian Freitas


True/​​​DTAC: Merger Support Increasingly Tenuous

By David Blennerhassett

  • Reportedly, the board of the National Broadcasting and Telecommunications Commission (NBTC), Thailand’s telco regulator, has called for a more detailed analysis of the deal’s impact on competition, consumers and industry. 
  • This follows recent calls by Thailand’s opposition Move Forward party urging the NBTC to block Total Access Communication (DTAC TB) / True Corp Pcl (TRUE TB)‘s merger.
  • Both DTAC and True are trading tight to terms – especially True. Time to take down borrow.

Siemens Energy/Siemens Gamesa: Downwards Guidance

By Jesus Rodriguez Aguilar

  • Q3 2022 results were received as weak by the market. Guidance was (again) revised downwards. Otherwise, the takeover bid continues in the process of authorization by the CNMV.
  • I don’t expect any relevant changes in the offer: Siemens Energy already has control, operating problems persist and the financial position continues to deteriorate. Downwards risks to consensus estimates persist.
  • Gross spread is 0.33%. The estimated annual return is 1.63% (assuming settlement on 24 October). Sell on strength/tender during the offer in case there’s a (low probability) improvement in the offer.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Equity Bottom-Up: Softbank Group Shock Settlement of Forward Alibaba Contracts Is Worrisome and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Softbank Group Shock Settlement of Forward Alibaba Contracts Is Worrisome
  • Kirin: With Myanmar in the Rear-View Mirror, an Additional 30% Upside Is Quite Possible
  • Toshiba – Little Good News
  • Rakuten (Neutral) – Q2 22 Results Reaction: Mobile Losses Narrow but Little Good News Beyond That
  • Denso (6902) | No Reason to Be Uber-Bearish
  • Revisiting Galaxy Digital Post 2Q Earnings
  • Shakey’s Pizza: Q2 2022 Recovery Far Better Than Expectations, Management Guidance Extremely Bullish
  • Pharmaessentia Corp (6446 TT): Key Marketed Drug Besremi Is Showing No Sign of Slow Down
  • ACCO: Inflationary Headwind
  • XPER: Ready for a Split

Softbank Group Shock Settlement of Forward Alibaba Contracts Is Worrisome

By Kirk Boodry

  • Softbank will settle all of its forward derivative contracts on Alibaba by the end of September, representing 242mn ADRs. Some had years to run so this is truly surprising
  • We estimate Softbank Group (9984 JP) raised $35b selling BABA-linked derivatives since mid-2020, which would imply average proceeds per ADR of $145 versus the $91 it trades at now
  • But early settlement also has us wondering when the other show will drop and if that is related to global tech, China or Alibaba specifically 

Kirin: With Myanmar in the Rear-View Mirror, an Additional 30% Upside Is Quite Possible

By Oshadhi Kumarasiri

  • Kirin Holdings (2503 JP)’s 2Q22 normalized OP of ¥46.2bn from ¥500.3bn revenue was slightly above the consensus OP of ¥45.9bn from ¥500.8bn revenue.
  • Kirin raised its 2022 revenue and normalized OP guidance by ¥40.0bn and ¥6.0bn respectively, due to the progress of profit improvement measures mainly in Coke-Northeast and Kyowa Kirin in 1H22.
  • Meanwhile, Kirin is due ¥22.4bn from MEHL for the Myanmar JV. Even though this is not the fair value, receiving at least something is a bonus in our opinion.

Toshiba – Little Good News

By Mio Kato

  • Toshiba reported 1Q results today missing at both the revenue and OP lines. 
  • While revenue was barely above consensus the company generate a ¥4.8bn operating loss rather than the ¥22bn OP consensus was projecting. 
  • 1Q is seasonally weak so the loss itself would not be concerning except for how widespread deterioration was.

Rakuten (Neutral) – Q2 22 Results Reaction: Mobile Losses Narrow but Little Good News Beyond That

By Kirk Boodry

  • Mobile losses narrowed sequentially as expected but not by much as the company missed consensus and Redex expectations for profitability
  • Rakuten also reported a 220K net subscriber loss in the quarter as point-chasing free users churned off when zero-yen tiers were cancelled but worringly, network coverage/capacity was also a factor
  • If there is a silver lining, fintech businesses Rakuten Bank and Securities posted solid results and remain on pace to IPO but negative mobile sentiment is unlikely to change

Denso (6902) | No Reason to Be Uber-Bearish

By Mark Chadwick

  • Denso started the fiscal year with an overly optimistic view of Toyota production – it is now too bearish 
  • Chip shortages and supply disruptions are starting to ease, making it easier for automakers to meet end demand 
  • We are bullish on the stock as we believe that Denso’s earnings will beat lowered guidance and valuations are at the bottom of the range 

Revisiting Galaxy Digital Post 2Q Earnings

By Rose Choy

  • Galaxy reported 2Q earnings this week and revealed a net loss of over $550 million, driven by realized and unrealized losses in both digital assets and investments.
  • With $1 billion cash, Galaxy is now in “clean up” mode but could deploy cash for potential M&A. Management sounds cautious and favors asset management business over other proprietary segments.
  • However, the current cost base run-rate looks high and despite undemanding stock valuation, we believe upside is capped.

Shakey’s Pizza: Q2 2022 Recovery Far Better Than Expectations, Management Guidance Extremely Bullish

By Sameer Taneja

  • Shakey’s Pizza (PIZZA PM) reported a strong SWS of 77% YoY in H1 and 121% YoY in Q2 2022. Excluding Potato Corner (PC), recovery tracked >90% of 2019 levels. 
  • The management guided that ex-PC recovery was over 100% in May and July, and numbers will improve with a resurgence in people at work, resulting in an upside to SWS.
  • We see margin upside as dine-in numbers are set to increase in H2 and the company beds down its PC acquisition; the stock trades at 16x/10x FY22/FY23e.

Pharmaessentia Corp (6446 TT): Key Marketed Drug Besremi Is Showing No Sign of Slow Down

By Tina Banerjee

  • Pharmaessentia Corp (6446 TT) is on a robust growth path following the U.S. launch of its key drug Besremi for polycythemia vera (PV) in December 2021.
  • The company has reported July net revenue of NT$348.5 million, an increase of 937% and 26% from July 2021 and June 2022, respectively.
  • Besremi has further label expansion opportunity as the drug is undergoing clinical trials for additional indications including essential thrombocythemia (ET), myelofibrosis, and chronic hepatitis.

ACCO: Inflationary Headwind

By Hamed Khorsand

  • Strong back to school sell-in was not enough to offset the impact of a weaker Euro and slowdown in video game spending
  • The weaker Euro to the US Dollar was expected in our numbers when we revised them in July. However, the drop off was more meaningful than expected
  • The decline in video game accessory sales also put pressure on the quarter with ACCO now expecting a “reset” in the segment’s performance

XPER: Ready for a Split

By Hamed Khorsand

  • XPER is in the final stages of separating its IP business from its product business.
  • The Company reported second quarter results in line with our updated estimates after announcing the purchase of Vewd Software and an IP license agreement
  • XPER’s multiple revenue streams gives the Company the ability to grow free cash flow even though one segment could be lagging

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thailand: Betagro Group, True Corp Pcl and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Betagro Pre-IPO – The Positives – Vertically Integrated and Weathered COVID Well
  • True/​​​DTAC: Merger Support Increasingly Tenuous

Betagro Pre-IPO – The Positives – Vertically Integrated and Weathered COVID Well

By Clarence Chu

  • Betagro Group (1737144D TB) is looking to raise about US$600m in its upcoming Thailand IPO.
  • Betagro is an integrated agro-industrial and food business in Thailand. The firm’s products cover all stages of the food value chain including upstream, midstream and downstream.
  • Betagro operates a vertically integrated model with its own production and processing capabilities. Furthermore, it utilizes a range of distribution channels for both domestic and international sales.

True/​​​DTAC: Merger Support Increasingly Tenuous

By David Blennerhassett

  • Reportedly, the board of the National Broadcasting and Telecommunications Commission (NBTC), Thailand’s telco regulator, has called for a more detailed analysis of the deal’s impact on competition, consumers and industry. 
  • This follows recent calls by Thailand’s opposition Move Forward party urging the NBTC to block Total Access Communication (DTAC TB) / True Corp Pcl (TRUE TB)‘s merger.
  • Both DTAC and True are trading tight to terms – especially True. Time to take down borrow.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief South Korea: Kakao Games Corp and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Kakao Games: Announces A Rights Offering Worth 197 Billion Won

Kakao Games: Announces A Rights Offering Worth 197 Billion Won

By Douglas Kim

  • Kakao Games Corp (293490 KS) announced today a rights offering worth 197 billion won, representing 4.4% of its market cap.
  • Lionheart Studio’s founder and CEO Kim Jae-Young is expected to purchase 3.1 million shares of the rights offering (177 billion won), representing 90% of the total rights offering shares.
  • The issue with Kakao Games and Lionheart Studio remains the fact that many investors would rather invest in Lionheart when it completes its IPO, rather than indirectly through Kakao Games.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: Softbank Group, Lite On Technology, Canon Inc, Kakao Games Corp, True Corp Pcl, Xperi, Arlo Technologies Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Softbank Confirms BABA Selldown – Big Changes on Softie’s Balance Sheet and BABA Index Implications
  • FTSE TWSE Taiwan Dividend+ Index Rebalance Preview: BIG Capping Changes in September
  • Softbank Group Shock Settlement of Forward Alibaba Contracts Is Worrisome
  • Looking at Canon Buyback Dynamics History – Patterns Vs Peers Gives Execution Hints
  • Kakao Games: Announces A Rights Offering Worth 197 Billion Won
  • True/​​​DTAC: Merger Support Increasingly Tenuous
  • XPER: Ready for a Split
  • ARLO: Capturing Paid Subscriber Growth

Softbank Confirms BABA Selldown – Big Changes on Softie’s Balance Sheet and BABA Index Implications

By Travis Lundy

  • Softbank today confirmed that the stories circulating about Softbank having hedged a decent portion – 200+mm shares – of its BABA position were true. 
  • The market expectation had been that these pre-paid forwards would be held for another two years. The announcement today is that they will be physically settled early. 
  • This means the entire accounting effect – worth ¥4.6trln – will hit the income statement (and balance sheet) in the current quarter. There are investment and index implications

FTSE TWSE Taiwan Dividend+ Index Rebalance Preview: BIG Capping Changes in September

By Brian Freitas

  • We do not expect any deletions from the FTSE TWSE Taiwan Dividend+ Index in September, but there will be a lot of passive flow due to capping changes.
  • Based on the closing prices from 9 August, we estimate one-way turnover of 11.2% at the September rebalance resulting in a one-way trade of TWD 15,754m (US$525m).
  • Most stocks with expected passive inflows are trading near their recent lows (leading to higher dividend yield), while most stocks with expected passive outflows have rallied recently (lower dividend yields).

Softbank Group Shock Settlement of Forward Alibaba Contracts Is Worrisome

By Kirk Boodry

  • Softbank will settle all of its forward derivative contracts on Alibaba by the end of September, representing 242mn ADRs. Some had years to run so this is truly surprising
  • We estimate Softbank Group (9984 JP) raised $35b selling BABA-linked derivatives since mid-2020, which would imply average proceeds per ADR of $145 versus the $91 it trades at now
  • But early settlement also has us wondering when the other show will drop and if that is related to global tech, China or Alibaba specifically 

Looking at Canon Buyback Dynamics History – Patterns Vs Peers Gives Execution Hints

By Travis Lundy

  • Canon Inc (7751 JP) has just started its 17th buyback in 15 years. Like the 16 before, this one is for ¥50bn. 
  • The patterns/dynamics of the canon buybacks in the past are remarkable when compared to buybacks of other companies. 
  • There are outperformance and under-performance patterns vs Peers, and it is worth taking note if you have a position to trade. 

Kakao Games: Announces A Rights Offering Worth 197 Billion Won

By Douglas Kim

  • Kakao Games Corp (293490 KS) announced today a rights offering worth 197 billion won, representing 4.4% of its market cap.
  • Lionheart Studio’s founder and CEO Kim Jae-Young is expected to purchase 3.1 million shares of the rights offering (177 billion won), representing 90% of the total rights offering shares.
  • The issue with Kakao Games and Lionheart Studio remains the fact that many investors would rather invest in Lionheart when it completes its IPO, rather than indirectly through Kakao Games.

True/​​​DTAC: Merger Support Increasingly Tenuous

By David Blennerhassett

  • Reportedly, the board of the National Broadcasting and Telecommunications Commission (NBTC), Thailand’s telco regulator, has called for a more detailed analysis of the deal’s impact on competition, consumers and industry. 
  • This follows recent calls by Thailand’s opposition Move Forward party urging the NBTC to block Total Access Communication (DTAC TB) / True Corp Pcl (TRUE TB)‘s merger.
  • Both DTAC and True are trading tight to terms – especially True. Time to take down borrow.

XPER: Ready for a Split

By Hamed Khorsand

  • XPER is in the final stages of separating its IP business from its product business.
  • The Company reported second quarter results in line with our updated estimates after announcing the purchase of Vewd Software and an IP license agreement
  • XPER’s multiple revenue streams gives the Company the ability to grow free cash flow even though one segment could be lagging

ARLO: Capturing Paid Subscriber Growth

By Hamed Khorsand

  • ARLO continues to demonstrate the strength of its paid subscription service by reporting its third straight quarter of non-GAAP net income.
  • ARLO’s ability to grow the number of paid subscribers each quarter has pushed the business to achieve annual recurring revenue (“ARR”) of $116.6 million
  • ARLO added 206 thousand paid subscribers in the second quarter. This was the second straight quarter where the number of net additions was over 200 thousand for the quarter

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Australia: GQG Partners and more

By | Australia, Daily Briefs

In today’s briefing:

  • GQG Partners IPO Lock-Up – Tightly Held by Founders, PAC Could Exit

GQG Partners IPO Lock-Up – Tightly Held by Founders, PAC Could Exit

By Sumeet Singh

  • GQG Partners (GQG) raised US$868m in its Australia IPO in Oct 2021. Its IPO linked lockup is set to expire soon.
  • GQG is a global investment boutique with a focus on managing active equity portfolios.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: GQG Partners, Shinoken Group, Galaxy, Times China and more

By | Daily Briefs, Financials

In today’s briefing:

  • GQG Partners IPO Lock-Up – Tightly Held by Founders, PAC Could Exit
  • Shinoken (8909) MBO – Decent Premium, Still Light, Will Someone Push?
  • Revisiting Galaxy Digital Post 2Q Earnings
  • Morning Views Asia: Greenland Holdings Corp, Lenovo, Longfor Properties, Softbank Group, Times China

GQG Partners IPO Lock-Up – Tightly Held by Founders, PAC Could Exit

By Sumeet Singh

  • GQG Partners (GQG) raised US$868m in its Australia IPO in Oct 2021. Its IPO linked lockup is set to expire soon.
  • GQG is a global investment boutique with a focus on managing active equity portfolios.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

Shinoken (8909) MBO – Decent Premium, Still Light, Will Someone Push?

By Travis Lundy

  • Today Shinoken Group (8909 JP) announced it was the subject of an MBO where the CEO-founder invited Integral – a local PE fund – to help him restructure and grow.
  • It is at a 45% premium to last, and management negotiated the price from a relatively insulting initial bid of ¥1,300 to ¥1,600 in the end, but it’s still light.
  • It is not hugely light, but it is not a full price. It could definitely be a bit higher. The question is whether active foreigners will push. 

Revisiting Galaxy Digital Post 2Q Earnings

By Rose Choy

  • Galaxy reported 2Q earnings this week and revealed a net loss of over $550 million, driven by realized and unrealized losses in both digital assets and investments.
  • With $1 billion cash, Galaxy is now in “clean up” mode but could deploy cash for potential M&A. Management sounds cautious and favors asset management business over other proprietary segments.
  • However, the current cost base run-rate looks high and despite undemanding stock valuation, we believe upside is capped.

Morning Views Asia: Greenland Holdings Corp, Lenovo, Longfor Properties, Softbank Group, Times China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Toshiba Corp, Siemens Gamesa Renewable Energy, S.A., Zoomlion Heavy Industry H, ACCO Brands and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Toshiba – Little Good News
  • Siemens Energy/Siemens Gamesa: Downwards Guidance
  • Zoomlion – Tear Sheet – Lucror Analytics
  • ACCO: Inflationary Headwind

Toshiba – Little Good News

By Mio Kato

  • Toshiba reported 1Q results today missing at both the revenue and OP lines. 
  • While revenue was barely above consensus the company generate a ¥4.8bn operating loss rather than the ¥22bn OP consensus was projecting. 
  • 1Q is seasonally weak so the loss itself would not be concerning except for how widespread deterioration was.

Siemens Energy/Siemens Gamesa: Downwards Guidance

By Jesus Rodriguez Aguilar

  • Q3 2022 results were received as weak by the market. Guidance was (again) revised downwards. Otherwise, the takeover bid continues in the process of authorization by the CNMV.
  • I don’t expect any relevant changes in the offer: Siemens Energy already has control, operating problems persist and the financial position continues to deteriorate. Downwards risks to consensus estimates persist.
  • Gross spread is 0.33%. The estimated annual return is 1.63% (assuming settlement on 24 October). Sell on strength/tender during the offer in case there’s a (low probability) improvement in the offer.

Zoomlion – Tear Sheet – Lucror Analytics

By Shu Hui Woon

We view Zoomlion as “High Risk” on the LARA scale, mainly due to its moderate financial profile. The company has concentrated exposure to China’s construction machinery segment, which is in turn reliant on infrastructure and construction spending in the country. Furthermore, a downturn in the property sector has had an indirect impact on Zoomlion. Globally, the industry is dominated by a few MNCs.

Zoomlion has a strong domestic market position, and is the world’s seventh-largest heavy machinery manufacturer. The company enjoys a close affiliation with the Chinese government, with its largest shareholder being a SOE. This improves Zoomlion’s access to refinancing capital. We expect the construction machinery industry to benefit from rising replacement demand and infrastructure development.

Our Credit Bias on Zoomlion is “Stable”, reflecting the company’s stable revenue. That said, we remain cautious about the likelihood of overdue risks resulting from the tough economic conditions. Additionally, capex has increased significantly and is expected to remain high, given the need to construct relocated plants and upgrade the company’s products. Overall investor sentiment is supported by Zoomlion’s operating track record and its largest shareholder, Hunan Xing Xiang Investment (a SOE). This may facilitate continued access to domestic debt markets.

Controversies are “Immaterial” and the ESG Impact on Credit is “Neutral”.


ACCO: Inflationary Headwind

By Hamed Khorsand

  • Strong back to school sell-in was not enough to offset the impact of a weaker Euro and slowdown in video game spending
  • The weaker Euro to the US Dollar was expected in our numbers when we revised them in July. However, the drop off was more meaningful than expected
  • The decline in video game accessory sales also put pressure on the quarter with ACCO now expecting a “reset” in the segment’s performance

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Health Care: Pharmaessentia Corp, Assertio Holdings and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Pharmaessentia Corp (6446 TT): Key Marketed Drug Besremi Is Showing No Sign of Slow Down
  • ASRT: Low Valuation Growth

Pharmaessentia Corp (6446 TT): Key Marketed Drug Besremi Is Showing No Sign of Slow Down

By Tina Banerjee

  • Pharmaessentia Corp (6446 TT) is on a robust growth path following the U.S. launch of its key drug Besremi for polycythemia vera (PV) in December 2021.
  • The company has reported July net revenue of NT$348.5 million, an increase of 937% and 26% from July 2021 and June 2022, respectively.
  • Besremi has further label expansion opportunity as the drug is undergoing clinical trials for additional indications including essential thrombocythemia (ET), myelofibrosis, and chronic hepatitis.

ASRT: Low Valuation Growth

By Hamed Khorsand

  • Reporting better than expected Q2 results was not enough to keep investors interested after the earnings release 
  • ASRT is in the process of broadening its sales channel for its recently acquired drug, Otrexup. ASRT should begin to generate a return on the drug in 2H2022
  • Indocin volume rose by approximately 7 percent sequentially. ASRT had increased prices in the second half of last year with investors concerned ASRT could face pushback from hospitals on pricing

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars